| abstract |
The present disclosure provides antibody molecules that bind to TCR V β regions and multispecific molecules comprising the antibody molecules. Furthermore, nucleic acids encoding the same, methods of producing the above molecules, pharmaceutical compositions comprising the above molecules and methods of treating infectious diseases using the above molecules are disclosed. |